lungcelltherapy.com
Read about the eligibility criteria for the LUN-202 NSCLC clinical trial which seeks to determine the safety and efficacy of TIL therapy.
Social
N/A
App
Category
Monetization
Unknown
Domain Information
WHOIS
Date
Created
2020-06-22
Expires
2027-06-22
NS Servers
ns-301.awsdns-37.com
ns-1316.awsdns-36.org
ns-1715.awsdns-22.co.uk
ns-653.awsdns-17.net
DNS Records
A
13.32.205.80
US
13.32.205.109
US
13.32.205.10
US
13.32.205.105
US
AWS CloudFront (GLOBAL)
TXT
google-site-verification=mFjJtw******nWs8
Google
Site Overview
Site Engagments
38.89%
Bounce Rate
Pages Per Visit
1
Total Visits
3.1K
Time on Site
00:00:11
Traffic Sources
Social
6.73%
Paid
1.80%
Mail
0.21%
Referrals
13.65%
Search
38.50%
Direct
38.06%
Traffic Top 5 Country
41.04%
23.88%
19.30%
15.77%
Review Score
UnknownGoogle Ads Overview
No ads shown in the past year.
Google SEO Overview
Top 5 Competitors (US)
Top 5 Keywords (US)
iovance
iovance biotherapeutics
iovance til
iovance biotherapeutics locations
clinical trial lung cancer
Top 5 Pages (US)
TopKeywordiovance
TopKeywordiov lun 202
TopKeywordiovance til
TopKeywordiovance biotherapeutics tampa
TopKeywordiovance tils
Google Indexing Results Overview(About Unknown Results)
Posts
| Title | Author | View | Comments | Last Update |
|---|